Oxford Immunotec Global PLC (CIK: 0001586049) EDGAR, Information, Filings... CompaniesBIO.Com

Oxford Immunotec Global PLC

Mailing address
94C INNOVATION DRIVE, MILTON PARK, ABINGDON, United Kingdom, OX14 4RZ
Phone
44 01235 442780
State location
United Kingdom
State of incorporation
United Kingdom
Fiscal year end
December 31
SIC
2835 - (CF Office: Office of Life Sciences) IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Filings
N/A

Oxford Immunotec Global PLC (CIK: 0001586049) is an American company incorporated in the state of United Kingdom. Head office is located at 94C INNOVATION DRIVE, MILTON PARK, ABINGDON, United Kingdom, OX14 4RZ. Work in the industry 2835 - (CF Office: Office of Life Sciences) IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES. Oxford Immunotec Global PLC is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
TOBIN JAMES R	0001190128	Mar-08-2021	director
ROSENMAN HERM	0001230057	Mar-08-2021	director
SANDBERG RICHARD A	0001245055	Mar-08-2021	director
RANDALL PATRICIA	0001272779	Mar-08-2021	director
BALTHROP PATRICK J	0001284839	Mar-08-2021	director
ANDREWS RONALD ASBURY	0001299153	Mar-08-2021	director
Walton Andrew Scott	0001384994	Mar-08-2021	director
Wrighton-Smith Peter	0001592286	Mar-08-2021	director, officer: Chief Executive Officer
Klausner Mark R.	0001732629	Mar-08-2021	director
McLaughlin Matthew T E	0001773442	Mar-08-2021	officer: Chief Financial Officer
Kidd Janet Louise	0001794297	Mar-08-2021	officer: General Counsel
Linn Stefan C	0001604050	Aug-28-2017	officer: Chief Operating Officer
Wenstrup Richard	0001645683	Jul-24-2017	officer: Chief Medical Officer
Keiley Elizabeth M	0001629085	Jan-01-2015	officer: VP & General Counsel
STEINMETZ MICHAEL	0001166285	Nov-21-2013	director, 10 percent owner
Chambon Philippe O.	0001192212	Nov-21-2013	10 percent owner
NIEDEL JAMES	0001231092	Nov-21-2013	10 percent owner
HUNT RONALD	0001247851	Nov-21-2013	10 percent owner
HENNER DENNIS	0001249153	Nov-21-2013	10 percent owner
GALAKATOS NICHOLAS	0001252522	Nov-21-2013	10 percent owner
LIPTAK ROBERT	0001252523	Nov-21-2013	10 percent owner
WHEELER KURT	0001252525	Nov-21-2013	10 percent owner
Lathi Vijay K	0001340806	Nov-21-2013	director, 10 percent owner
Spotts Stephen L	0001413746	Nov-21-2013	director
Simon Nicholas	0001431403	Nov-21-2013	10 percent owner
Clarus Ventures I, LLC	0001431441	Nov-21-2013	10 percent owner
Clarus Lifesciences I, L.P.	0001431445	Nov-21-2013	10 percent owner
New Leaf Ventures II, L.P.	0001441439	Nov-21-2013	director, 10 percent owner
Delagardelle Jeani	0001441563	Nov-21-2013	10 percent owner
New Leaf Venture Management II, L.L.C.	0001441857	Nov-21-2013	director, 10 percent owner
New Leaf Venture Associates II, L.P.	0001441858	Nov-21-2013	director, 10 percent owner
Clarus Ventures I Management, L.P.	0001505590	Nov-21-2013	10 percent owner
Ratcliffe Liam	0001547100	Nov-21-2013	10 percent owner
Schroeder Jeff R.	0001592272	Nov-21-2013	officer: Chief Commercial Officer
Edwardson Peter	0001592279	Nov-21-2013	officer: Chief Operations Officer
Pitchford Nigel A.	0001592349	Nov-21-2013	director
Altieri Richard M.	0001592351	Nov-21-2013	officer: Chief Financial Officer

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Oxford Immunotec Global PLC

Filings	Format	Description	Filed/Effective	File/Film Number
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001172661-22-000722 (34 Act) Size: KB	Feb-14-2022	005-87926 22630479
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001172661-22-000470 (34 Act) Size: KB	Feb-14-2022	005-87926 22626968
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001157523-21-000631 (34 Act) Size: KB	May-07-2021	005-87926 21903809
15-12B	Document	Notice of termination of registration of a class of securities under Section 12(b) Acc-no: 0001140361-21-009093 (34 Act) Size: KB	Mar-18-2021	001-36200 21754811
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001140361-21-008354 (33 Act) Size: KB	Mar-12-2021	333-193730 21738022
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001140361-21-008353 ( Act) Size: 0 KB	Mar-12-2021
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001140361-21-008351 ( Act) Size: 0 KB	Mar-12-2021
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001140361-21-008349 ( Act) Size: 0 KB	Mar-12-2021
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001140361-21-008348 ( Act) Size: 0 KB	Mar-12-2021
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001140361-21-008346 ( Act) Size: 0 KB	Mar-12-2021
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001140361-21-008347 ( Act) Size: 0 KB	Mar-12-2021
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001140361-21-008343 ( Act) Size: 0 KB	Mar-12-2021
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001140361-21-008344 ( Act) Size: 0 KB	Mar-12-2021
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001140361-21-008342 ( Act) Size: 0 KB	Mar-12-2021
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001140361-21-008340 ( Act) Size: 0 KB	Mar-12-2021
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001140361-21-008338 ( Act) Size: 0 KB	Mar-12-2021
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001140361-21-008339 (33 Act) Size: KB	Mar-12-2021	333-192582 21737955
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001076809-21-000138 (34 Act) Size: KB	Mar-08-2021	005-87926 21722806
8-K	Document	Current report filing Acc-no: 0001140361-21-007653 (34 Act) Size: KB	Mar-08-2021	001-36200 21722424
25-NSE	Document	Acc-no: 0001354457-21-000310 (34 Act) Size: KB	Mar-08-2021	001-36200 21720769

Recent 20 filings. View all Oxford Immunotec Global PLC filings

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Oxford Immunotec Global PLC overview
Oxford Immunotec Global PLC job
Oxford Immunotec Global PLC stock
Oxford Immunotec Global PLC ownership
Oxford Immunotec Global PLC CEO
Oxford Immunotec Global PLC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.